Spinal Tech

For the first time in its history Stryker's full-year sales surpassed $20 billion in 2023, the devicemaker said Jan. 8.

Orthofix named Julie Andrews as its new CFO, the devicemaker said Jan. 8.

Here are eight key updates from spine and orthopedic devicemakers since Feb. 7.

Stryker is expected to have a strong financial year in 2024, driven in part by the upcoming launch of its Mako shoulder and spine applications, according to a Dec. 31 report from Seeking Alpha. 

The global spinal fusion device market is expected to reach $9.9 billion by 2030, according to a report from Renub Research.

Spine and orthopedic products company Orthofix released new data on pulsed electromagnetic field stimulation, an additional therapy to lumbar spinal fusion procedures for patients at risk for pseudarthrosis.

Life Spine settled its litigation agianst Aegis Spine and secured a court order permanently prohibiting marketing or sales of AccelFix-XT devices in the U.S., according to a Dec. 21 news release.

Ulrich Medica USA earned FDA clearance to expand indications for its Momemtum and Momentum minimally invasive posterior spine systems, the company said Dec. 20.

ZimVie is selling its spine business to HIG Capital for $375 million. 

There have been several spine and orthopedic legal disputes involving device patents in the last two years. Some have involved different companies, and others have involved surgeons.